Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Rocket Pharmaceuticals (DE:9IP1)
FRANKFURT:9IP1
RESEARCH TOOLSreports
Holding DE:9IP1?
Track your performance easily
Rocket Pharmaceuticals (9IP1) Ownership Overview
20.55% Insiders
27.97% Mutual Funds
12.13% Other Institutional Investors
12.81% ETFs
26.54% Public Companies and
Individual Investors
The ownership structure of Rocket Pharmaceuticals (DE:9IP1) stock is a mix of institutional, retail, and individual investors. Approximately 52.91% of the company’s stock is owned by Institutional Investors, 20.55% is owned by Insiders, and 26.54% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Nov 04, 2024 | Mark Andrew White General Manager, Commercial Affairs | xxxxxxxxxxxxx | $51190 |
| Nov 04, 2024 | John Militello Vp Of Finance, Treasurer, Principal Accounting Officer | xxxxxxxxxxxxx | $15241 |
| Aug 20, 2024 | John Militello Vp Of Finance, Treasurer, Principal Accounting Officer | xxxxxxxxxxxxx | $19684 |
| Aug 20, 2024 | Gaurav Shah Ceo,director | xxxxxxxxxxxxx | $178525 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Jun 30, 2024 | xxxxxxxxxxxxx | $3244700 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $4049793 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $12099127 | |
| Jun 30, 2024 | xxxxxxxxxxxxx | $26839233 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 16,272,635 | Insider | 17.85% | 266,985,122 | |
| 6,490,225 | Institution | 7.12% | 106,485,122 | |
| 5,259,477 | Institution | 5.77% | 86,292,239 | |
| 4,945,694 | Institution | 5.43% | 81,144,001 | |
| 3,928,312 | Institution | 4.31% | 64,451,815 | |
| 3,370,420 | Institution | 3.70% | 55,298,481 | |
| 1,676,182 | Institution | 1.84% | 27,501,118 | |
| 1,246,597 | Institution | 1.37% | 20,452,917 | |
| 1,244,794 | Institution | 1.37% | 20,423,335 | |
| 1,124,657 | Insider | 1.23% | 18,452,247 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 6,490,225 | Institution | 7.12% | 106,485,122 | |
| 4,945,694 | Institution | 5.43% | 81,144,001 | |
| 1,244,794 | Institution | 1.37% | 20,423,335 | |
| 1,027,618 | Institution | 1.13% | 16,860,129 | |
| 1,011,983 | Institution | 1.11% | 16,603,605 | |
| 989,051 | Institution | 1.08% | 16,227,360 | |
| 770,691 | Institution | 0.85% | 12,644,727 | |
| 762,367 | Institution | 0.84% | 12,508,155 | |
| 736,753 | Institution | 0.81% | 12,087,906 | |
| 690,270 | Institution | 0.76% | 11,325,260 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Rocket Pharmaceuticals (DE:9IP1)?
According to the latest TipRanks data, approximately 12.13% of the company's stock is held by institutional investors, 20.55% is held by insiders, and 26.54% is held by retail investors.
What percentage of Rocket Pharmaceuticals (DE:9IP1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 12.13% of Rocket Pharmaceuticals (DE:9IP1) stock is held by institutional investors.
What percentage of Rocket Pharmaceuticals (DE:9IP1) stock is held by retail investors?
According to the latest TipRanks data, approximately 26.54% of Rocket Pharmaceuticals (DE:9IP1) stock is held by retail investors.
Who owns the most shares of Rocket Pharmaceuticals (DE:9IP1)?
RODERICK WONG owns the most shares of Rocket Pharmaceuticals (DE:9IP1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.